<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:07:45Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13539" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13539</identifier><datestamp>2026-10-18T21:13:29Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Effect of rutin on cytarabine-associated pulmonary oedema and oxidative stress in rats</dc:title><dc:creator>Bilgin, Asli O.</dc:creator><dc:creator>Mammadov, Renad</dc:creator><dc:creator>Suleyman, Bahadir</dc:creator><dc:creator>Unver, Edhem</dc:creator><dc:creator>Ozcicek, Fatih</dc:creator><dc:creator>Soyturk, Mehmet</dc:creator><dc:creator>Cimen, Ferda K.</dc:creator><dc:creator>Kurt, Nezahat</dc:creator><dc:creator>Suleyman, Halis</dc:creator><dc:subject>Cytarabine</dc:subject><dc:subject>Oxidative stress</dc:subject><dc:subject>Pulmonary oedema</dc:subject><dc:subject>Rutin</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Anti-Inflammatory Agents</dc:subject><dc:subject>Antioxidants</dc:subject><dc:subject>Male</dc:subject><dc:subject>NF-kappa B</dc:subject><dc:subject>Oxidants</dc:subject><dc:subject>Pulmonary Edema</dc:subject><dc:subject>Rats</dc:subject><dc:subject>Rats, Wistar</dc:subject><dc:subject>Tumor Necrosis Factor-alpha</dc:subject><dc:subject>antiinflammatory agent</dc:subject><dc:subject>antioxidant</dc:subject><dc:subject>immunoglobulin enhancer binding protein</dc:subject><dc:subject>oxidizing agent</dc:subject><dc:subject>rutoside</dc:subject><dc:subject>tumor necrosis factor</dc:subject><dc:subject>animal</dc:subject><dc:subject>blood</dc:subject><dc:subject>drug effect</dc:subject><dc:subject>lung edema</dc:subject><dc:subject>pathology</dc:subject><dc:subject>rat</dc:subject><dc:subject>Wistar rat</dc:subject><dc:description>Cytarabine is effectively used in the treatment of adult acute leukemia, but it has a dose-limiting side effect of fatal pulmonary oedema because it increases the vascular permeability of the alveolar capillaries. The aim of the present study was to conduct a radiological, biochemical and histopathological investigation of the effect of rutin on cytarabine-associated pulmonary oedema in rats. Rats were treated with a combination of rutin+cytarabine by administering oral rutin at a dose of 50 mg/kg; other rat groups were orally administered the same volume of physiological saline. One hour after administration of rutin or saline, the rutin+cytarabine and cytarabine groups received an intraperitoneal injection of cytarabine (200 mg/kg). This administration procedure was repeated once a day for 14 days. Radiologically, 50% of the animals given cytarabine alone showed lung oedema, but the rutin+cytarabine group showed no oedema. The inclusion of rutin decreased the amounts of cytarabine-associated malondialdehyde, tumour necrosis factor-α, and nuclear factor-κB in the lung tissue. Rutin also inhibited the reduction of total glutathione by nitric oxide. These findings suggest that rutin may be a beneficial adjunct that can minimise the development of cytarabine-associated pulmonary oedema. © 2020, Academia Brasileira de Ciencias. All rights reserved.</dc:description><dc:publisher>Academia Brasileira de Ciencias</dc:publisher><dc:date>2020</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13539</dc:identifier><dc:identifier>https://doi.org/10.1590/0001-3765202020190261</dc:identifier><dc:identifier>0001-3765</dc:identifier><dc:language>en</dc:language><dc:relation>Anais da Academia Brasileira de Ciencias</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13539</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>